{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:16:27Z","timestamp":1790172987989,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T00:00:00Z","timestamp":1450224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T00:00:00Z","timestamp":1450224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/ja.2015.127","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T07:24:28Z","timestamp":1450250668000},"page":"415-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii"],"prefix":"10.1038","volume":"69","author":[{"given":"Thien B","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Ee","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi H","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip J","family":"Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L","family":"Nation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J","family":"Creek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangning","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Velkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,16]]},"reference":[{"key":"BFja2015127_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/cid\/cit152","volume":"56","author":"HW Boucher","year":"2013","unstructured":"Boucher, H. W. et al. 10 x '20 Progress\u2014development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin. Infect. Dis. 56, 1685\u20131694 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2015127_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2217\/fmb.13.39","volume":"8","author":"T Velkov","year":"2013","unstructured":"Velkov, T., Roberts, K. D., Nation, R. L., Thompson, P. E. & Li, J. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics. Future Microbiol. 8, 711\u2013724 (2013).","journal-title":"Future Microbiol."},{"key":"BFja2015127_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","volume":"21","author":"AY Peleg","year":"2008","unstructured":"Peleg, A. Y., Seifert, H. & Paterson, D. L. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538\u2013582 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFja2015127_CR4","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1093\/jac\/dkq226","volume":"65","author":"RV Dudhani","year":"2010","unstructured":"Dudhani, R. V., Turnidge, J. D., Nation, R. L. & Li, J. fAUC\/MIC is the most predictive pharmacokinetic\/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. J. Antimicrob. Chemother. 65, 1984\u20131990 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2015127_CR5","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/AAC.01733-10","volume":"55","author":"SM Garonzik","year":"2011","unstructured":"Garonzik, S. M. et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob. Agents Chemother. 55, 3284\u20133294 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR6","doi-asserted-by":"crossref","unstructured":"Poulikakos, P., Tansarli, G. S. & Falagas, M. E. Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review. Eur. J. Clin. Microbiol. Infect. Dis. (2014).","DOI":"10.1007\/s10096-014-2124-9"},{"key":"BFja2015127_CR7","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/jac\/dks084","volume":"67","author":"Y Cai","year":"2012","unstructured":"Cai, Y., Chai, D., Wang, R., Liang, B. & Bai, N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J. Antimicrob. Chemother. 67, 1607\u20131615 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2015127_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nchembio.559","volume":"7","author":"L Ejim","year":"2011","unstructured":"Ejim, L. et al. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat. Chem. Biol. 7, 348\u2013350 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"BFja2015127_CR9","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1128\/AAC.00103-06","volume":"50","author":"J Li","year":"2006","unstructured":"Li, J. et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50, 2946\u20132950 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR10","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1128\/AAC.00834-10","volume":"54","author":"JH Moffatt","year":"2010","unstructured":"Moffatt, J. H. et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54, 4971\u20134977 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR11","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1128\/AAC.00865-13","volume":"57","author":"MR Pelletier","year":"2013","unstructured":"Pelletier, M. R. et al. Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii. Antimicrob. Agents Chemother. 57, 4831\u20134840 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos, A. P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect 18, 268\u2013281 (2012).","journal-title":"Clin. Microbiol. Infect"},{"key":"BFja2015127_CR13","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Second Informational Supplement (M100-S22). (2012)."},{"key":"BFja2015127_CR14","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1128\/AAC.05028-11","volume":"55","author":"PJ Bergen","year":"2011","unstructured":"Bergen, P. J. et al. Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula. Antimicrob. Agents Chemother. 55, 5134\u20135142 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR15","unstructured":"Pillai, S. K., Moellering, R. C. & Eliopoulos, G. M in Antibiotics in Laboratory Medicine (ed. Victor Lorian) Ch. 9, (Lippincott Williams & Wilkins, 2005)."},{"key":"BFja2015127_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1128\/AAC.04182-14","volume":"59","author":"SE Cheah","year":"2015","unstructured":"Cheah, S. E., Li, J., Nation, R. L. & Bulitta, J. B. Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies. Antimicrob. Agents Chemother. 59, 381\u2013388 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher, H. W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1\u201312 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2015127_CR18","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent, J. L. et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302, 2323\u20132329 (2009).","journal-title":"JAMA"},{"key":"BFja2015127_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1159\/000321018","volume":"56","author":"AN Kunz","year":"2010","unstructured":"Kunz, A. N. & Brook, I. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy 56, 492\u2013500 (2010).","journal-title":"Chemotherapy"},{"key":"BFja2015127_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","volume":"6","author":"J Li","year":"2006","unstructured":"Li, J. et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6, 589\u2013601 (2006).","journal-title":"Lancet Infect. Dis."},{"key":"BFja2015127_CR21","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1086\/429323","volume":"40","author":"ME Falagas","year":"2005","unstructured":"Falagas, M. E. & Kasiakou, S. K. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40, 1333\u20131341 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2015127_CR22","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/jac\/dkm305","volume":"60","author":"KS Ko","year":"2007","unstructured":"Ko, K. S. et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemother. 60, 1163\u20131167 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2015127_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/jac\/dkl512","volume":"59","author":"RJ Owen","year":"2007","unstructured":"Owen, R. J., Li, J., Nation, R. L. & Spelman, D. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J. Antimicrob. Chemother. 59, 473\u2013477 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2015127_CR24","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1128\/AAC.01571-06","volume":"51","author":"CH Tan","year":"2007","unstructured":"Tan, C. H., Li, J. & Nation, R. L. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic\/pharmacodynamic model. Antimicrob. Agents Chemother. 51, 3413\u20133415 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1473-3099(14)70850-3","volume":"15","author":"RL Nation","year":"2015","unstructured":"Nation, R. L. et al. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Lancet Infect. Dis. 15, 225\u2013234 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"BFja2015127_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1090-0233(05)80005-X","volume":"154","author":"RJ Martin","year":"1997","unstructured":"Martin, R. J. Modes of action of anthelmintic drugs. Vet. J. 154, 11\u201334 (1997).","journal-title":"Vet. J."},{"key":"BFja2015127_CR27","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1073\/pnas.0915125107","volume":"107","author":"C Gloeckner","year":"2010","unstructured":"Gloeckner, C. et al. Repositioning of an existing drug for the neglected tropical disease Onchocerciasis. Proc. Natl. Acad. Sci. USA 107, 3424\u20133429 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFja2015127_CR28","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1126\/science.158.3809.1694","volume":"158","author":"RL Williamson","year":"1967","unstructured":"Williamson, R. L. & Metcalf, R. L. Salicylanilides: a new group of active uncouplers of oxidative phosphorylation. Science 158, 1694\u20131695 (1967).","journal-title":"Science"},{"key":"BFja2015127_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijantimicag.2007.08.023","volume":"31","author":"S Omura","year":"2008","unstructured":"Omura, S Ivermectin: 25 years and still going strong. Int J. Antimicrob. Agents 31, 91\u201398 (2008).","journal-title":"Int J. Antimicrob. Agents"},{"key":"BFja2015127_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/03602538708998307","volume":"18","author":"M Michiels","year":"1987","unstructured":"Michiels, M., Meuldermans, W. & Heykants, J. The metabolism and fate of closantel (Flukiver) in sheep and cattle. Drug Metab. Rev. 18, 235\u2013251 (1987).","journal-title":"Drug Metab. Rev."},{"key":"BFja2015127_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2885.1987.tb00089.x","volume":"10","author":"NA Mohammed-Ali","year":"1987","unstructured":"Mohammed-Ali, N. A. & Bogan, J. A. The pharmacodynamics of the flukicidal salicylanilides, rafoxanide, closantel and oxyclosanide. J. Vet. Pharmacol. Ther. 10, 127\u2013133 (1987).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"BFja2015127_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/jac\/dks437","volume":"68","author":"AM Sandri","year":"2013","unstructured":"Sandri, A. M. et al. Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis. J. Antimicrob. Chemother. 68, 674\u2013677 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2015127_CR33","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/jac\/dkm357","volume":"60","author":"AP Zavascki","year":"2007","unstructured":"Zavascki, A. P., Goldani, L. Z., Li, J. & Nation, R. L. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J. Antimicrob. Chemother. 60, 1206\u20131215 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2015127_CR34","doi-asserted-by":"publisher","first-page":"953417","DOI":"10.1155\/2014\/953417","volume":"2014","author":"SS Lean","year":"2014","unstructured":"Lean, S. S. et al. Prevalence and genetic characterization of carbapenem- and polymyxin-resistant Acinetobacter baumannii isolated from a tertiary hospital in Terengganu, Malaysia. ISRN Microbiol. 2014, 953417 (2014).","journal-title":"ISRN Microbiol."},{"key":"BFja2015127_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/tid.12210","volume":"16","author":"MP Freire","year":"2014","unstructured":"Freire, M. P. et al. Polymyxin use as a risk factor for colonization or infection with polymyxin-resistant Acinetobacter baumannii after liver transplantation. Transpl. Infect. Dis. 16, 369\u2013378 (2014).","journal-title":"Transpl. Infect. Dis."},{"key":"BFja2015127_CR36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/1753425913493337","volume":"20","author":"T Velkov","year":"2014","unstructured":"Velkov, T. et al. Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae. Innate Immun. 20, 350\u2013363 (2014).","journal-title":"Innate Immun."},{"key":"BFja2015127_CR37","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1128\/AAC.05829-11","volume":"56","author":"SM Moskowitz","year":"2012","unstructured":"Moskowitz, S. M. et al. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients. Antimicrob. Agents Chemother. 56, 1019\u20131030 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1128\/AAC.01088-10","volume":"55","author":"C Urban","year":"2011","unstructured":"Urban, C., Tiruvury, H., Mariano, N., Colon-Urban, R. & Rahal, J. J. Polymyxin-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 55, 388\u2013389 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ja.2013.86","volume":"66","author":"MS Butler","year":"2013","unstructured":"Butler, M. S., Blaskovich, M. A. & Cooper, M. A. Antibiotics in the clinical pipeline in 2013. J. Antibiot. (Tokyo) 66, 571\u2013591 (2013).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFja2015127_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tim.2013.12.007","volume":"22","author":"TF Schaberle","year":"2014","unstructured":"Schaberle, T. F. & Hack, I. M. Overcoming the current deadlock in antibiotic research. Trends Microbiol. 22, 165\u2013167 (2014).","journal-title":"Trends Microbiol."},{"key":"BFja2015127_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1155\/2005\/892058","volume":"16","author":"J Conly","year":"2005","unstructured":"Conly, J. & Johnston, B. Where are all the new antibiotics? The new antibiotic paradox. Can. J. Infect. Dis. Med. Microbiol. 16, 159\u2013160 (2005).","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"BFja2015127_CR42","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/jac\/dkn425","volume":"62","author":"A Poudyal","year":"2008","unstructured":"Poudyal, A. et al. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae. J. Antimicrob. Chemother. 62, 1311\u20131318 (2008).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2015127_CR43","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1128\/AAC.02894-14","volume":"58","author":"TR Keepers","year":"2014","unstructured":"Keepers, T. R., Gomez, M., Celeri, C., Nichols, W. W . & Krause, K. M Bactericidal activity, absence of serum effect, and time-kill kinetics of ceftazidime-avibactam against beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 58, 5297\u20135305 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR44","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/jac\/dkr045","volume":"66","author":"F Robin","year":"2011","unstructured":"Robin, F. et al. In vitro efficiency of the piperacillin\/tazobactam combination against inhibitor-resistant TEM- and complex mutant TEM-producing clinical strains of Escherichia coli. J. Antimicrob. Chemother. 66, 1052\u20131056 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2015127_CR45","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0960-894X(98)00326-6","volume":"8","author":"DJ Hlasta","year":"1998","unstructured":"Hlasta, D. J. et al. Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel. Bioorg Med. Chem. Lett. 8, 1923\u20131928 (1998).","journal-title":"Bioorg Med. Chem. Lett."},{"key":"BFja2015127_CR46","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1021\/jm9803572","volume":"41","author":"MJ Macielag","year":"1998","unstructured":"Macielag, M. J. et al. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria. J. Med. Chem. 41, 2939\u20132945 (1998).","journal-title":"J. Med. Chem."},{"key":"BFja2015127_CR47","doi-asserted-by":"publisher","first-page":"e89189","DOI":"10.1371\/journal.pone.0089189","volume":"9","author":"R Rajamuthiah","year":"2014","unstructured":"Rajamuthiah, R. et al. Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus. PLoS ONE 9, e89189 (2014).","journal-title":"PLoS ONE"},{"key":"BFja2015127_CR48","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1021\/jm900999h","volume":"53","author":"T Velkov","year":"2010","unstructured":"Velkov, T., Thompson, P. E., Nation, R. L. & Li, J. Structure\u2014activity relationships of polymyxin antibiotics. J. Med. Chem. 53, 1898\u20131916 (2010).","journal-title":"J. Med. Chem."},{"key":"BFja2015127_CR49","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","volume":"43","author":"RE Hancock","year":"1999","unstructured":"Hancock, R. E. & Chapple, D. S. Peptide antibiotics. Antimicrob. Agents Chemother. 43, 1317\u20131323 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2015127_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden, K. A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol 3, 238\u2013250 (2005).","journal-title":"Nat. Rev. Microbiol"},{"key":"BFja2015127_CR51","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1021\/jm991031b","volume":"42","author":"P Pristovsek","year":"1999","unstructured":"Pristovsek, P. & Kidric, J. Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study. J. Med. Chem. 42, 4604\u20134613 (1999).","journal-title":"J. Med. Chem."},{"key":"BFja2015127_CR52","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1586\/14787210.5.6.951","volume":"5","author":"JD Hale","year":"2007","unstructured":"Hale, J. D. & Hancock, R. E. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti Infect. Ther. 5, 951\u2013959 (2007).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"BFja2015127_CR53","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1128\/AAC.00756-12","volume":"56","author":"TR Sampson","year":"2012","unstructured":"Sampson, T. R. et al. Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway. Antimicrob. Agents Chemother. 56, 5642\u20135649 (2012).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ja2015127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja2015127","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja2015127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:22:06Z","timestamp":1684430526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja2015127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,16]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFja2015127"],"URL":"https:\/\/doi.org\/10.1038\/ja.2015.127","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,16]]},"assertion":[{"value":"8 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}